Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Bacterial vaginosis, candidiasis and trichomoniasis

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Discharge with pelvic or pregnancy danger

Lower abdominal pain, cervical excitation, fever, sepsis, heavy bleeding, pregnancy pain, reduced fetal wellbeing or rapidly spreading vulval inflammation indicates disease beyond uncomplicated vaginitis.

Action: Use ABCDE when unwell, perform pregnancy testing and urgent pelvic assessment, obtain STI and microbiology samples without delaying treatment, and involve gynaecology, maternity or critical care for pelvic inflammatory disease, obstetric complication or invasive infection.

Synopsis

Distinguish the common causes of vaginal discharge by symptoms, examination and point-of-care or laboratory testing, then use diagnosis-specific treatment, pregnancy precautions and partner management.

  • Bacterial vaginosis typically causes thin homogeneous grey-white discharge and a fishy odour with little vulval inflammation.
  • Vulvovaginal candidiasis usually causes intense itch, soreness, erythema and thick white discharge; vaginal pH generally remains normal.
  • Trichomoniasis may cause offensive yellow-green or frothy discharge, vulval irritation and punctate cervical inflammation, but many infections are asymptomatic.
  • History and examination guide testing; symptoms alone are insufficient because mixed infection and non-infective vulval disease are common.
  • Use vaginal pH, microscopy or validated nucleic-acid testing according to the syndrome and local sexual-health pathway.
  • Treat bacterial vaginosis and trichomoniasis with a recommended nitroimidazole regimen, but trichomoniasis also requires partner treatment and sexual abstinence until completion.
  • Treat uncomplicated candidiasis with a topical azole or oral fluconazole; in pregnancy use topical azole therapy and avoid oral fluconazole.
  • Do not routinely treat asymptomatic bacterial-vaginosis partners or candidiasis partners unless they have symptoms.

Key red flags

Pelvic pain, cervical motion tenderness or adnexal tenderness suggests pelvic inflammatory disease rather than isolated vaginitis.

Fever, hypotension, severe vulval pain, necrosis or rapidly spreading erythema requires emergency assessment for invasive infection.

Pregnancy with pain, bleeding, contractions or reduced fetal movements needs same-day maternity assessment.

Persistent vulval ulceration, bleeding, skin change or a mass requires examination and possible biopsy rather than repeated empirical thrush treatment.

Recurrent candidiasis, severe infection or unusual species should prompt diabetes, immune and microbiological review.

Frothy discharge with urinary symptoms, exposure risk or a new partner warrants testing for trichomonas and other STIs.

Upper-genital-tract features

Deep dyspareunia, intermenstrual bleeding, pelvic pain, fever or cervical excitation requires assessment for PID.

Investigation priorities

01
Vaginal pHFirst step

Differentiate normal-pH candidiasis from pH elevation in bacterial vaginosis or trichomoniasis.

Management branches

ASSESSDefine the discharge syndrome

A patient presents with new vaginal discharge, odour, itch or vulval soreness.

  1. Ask onset, discharge, odour, itch, pain, bleeding, urinary symptoms, pregnancy possibility, antibiotics, diabetes, products and sexual exposures.
  2. Examine vulva and use speculum assessment when clinically appropriate, checking cervix, retained foreign body, ulcers and upper-tract tenderness.
  3. Perform pH and microscopy or send vaginal NAAT and culture according to local capability and recurrence status.
  4. Offer site-appropriate STI testing and HIV or syphilis screening according to exposure rather than assuming all discharge is candidiasis.

Key medicines

Metronidazole for bacterial vaginosisGive 400 mg orally twice daily for five to seven days, or use the exact locally approved intravaginal alternative.Review warfarin and lithium interactions, liver disease and neurological toxicity; advise following the product alcohol warning and seek pregnancy-specific guidance.
Clotrimazole for candidiasisGive a 500 mg intravaginal pessary once for uncomplicated disease; in pregnancy use a topical azole course for seven days.Intravaginal products may damage latex condoms or diaphragms temporarily; persistent or recurrent symptoms require examination and culture.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CKS Vaginal discharge
  • NICE CKS Candida: female genital
  • NICE CKS Trichomoniasis
  • NHS Bacterial vaginosis information

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom